Correspondence
Pharmacological treatments in pregnant women with psoriasis in the U.S.A.
Funding sources: The Center for Dermatology Research is supported by an unrestricted educational grant from Galderma Laboratories, L.P.
Conflicts of interest: S.R.F. is a consultant and speaker for Galderma, Stiefel/GlaxoSmithKline, Abbott Labs, Warner Chilcott, Janssen, Amgen, Photomedex, Genentech, BiogenIdec and Bristol Myers Squibb. He has received grants from Galderma, Astellas, Abbott Labs, Warner Chilcott, Janssen, Amgen, Photomedex, Genentech, BiogenIdec, Coria/Valeant, Pharmaderm, Ortho Pharmaceuticals, Aventis Pharmaceuticals, Roche Dermatology, 3M, Bristol Myers Squibb, Stiefel/GlaxoSmithKline, Novartis, Medicis, LEO Pharma, HanAll Pharmaceuticals, Celgene, Basilea and Anacor, and has received stock options from Photomedex. The other authors declare no conflicts of interest.
